Pathogenesis of giant-cell arteritis: How targeted therapies are influencing our understanding of the mechanisms involved

31Citations
Citations of this article
90Readers
Mendeley users who have this article in their library.

Abstract

GCA is a chronic granulomatous vasculitis that affects large- and medium-sized vessels. Both the innate and the adaptive immune system are thought to play an important role in the initial events of the pathogenesis of GCA. Amplification cascades are involved in the subsequent development and progression of the disease, resulting in vascular inflammation, remodelling and occlusion. The development of largevessel vasculitis in genetically modified mice has provided some evidence regarding potential mechanisms that lead to vascular inflammation. However, the participation of specific mechanistic pathways in GCA has not been fully established because of the paucity and limitations of functional models. Treatment of GCA is evolving, and novel therapies are being incorporated into the GCA treatment landscape. In addition, to improve the management of GCA, targeted therapies are providing functional proof of concept of the relevance of particular pathogenic mechanisms in the development of GCA and in sustaining vascular inflammation.

Cite

CITATION STYLE

APA

Terrades-Garcia, N., & Cid, M. C. (2018, February 1). Pathogenesis of giant-cell arteritis: How targeted therapies are influencing our understanding of the mechanisms involved. Rheumatology (United Kingdom). Oxford University Press. https://doi.org/10.1093/rheumatology/kex423

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free